The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of Genexus system that automates specimen-to-report for cancer genomic profiling within a day using liquid biopsy.
 
Siew-Kee Kee Low
Consulting or Advisory Role - Cancer Precision Medicine
Research Funding - Novartis
 
Ken Uchibori
Employment - Daiichi Sankyo (I)
 
Rie Hayashi
Employment - Cancer Precision Medicine
 
Hiu Ting Chan
No Relationships to Disclose
 
Ryo Ariyasu
No Relationships to Disclose
 
Satoru Kitazono
Honoraria - AstraZeneca; Chugai Pharma; Ono Pharmaceutical
 
Noriko Yanagitani
No Relationships to Disclose
 
Makoto Nishio
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; MSD; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AbbVie; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Teijin Pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Yusuke Nakamura
Stock and Other Ownership Interests - OncoTherapy Science
Consulting or Advisory Role - OncoTherapy Science
Research Funding - Cancer Precision Medicine